X-136875323-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001164803.2(RBMX):āc.392A>Gā(p.Glu131Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,097,910 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001164803.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBMX | NM_002139.4 | c.717A>G | p.Arg239Arg | synonymous_variant | 7/9 | ENST00000320676.11 | NP_002130.2 | |
RBMX | NM_001164803.2 | c.392A>G | p.Glu131Gly | missense_variant | 5/8 | NP_001158275.1 | ||
RBMX | NR_028476.2 | n.700A>G | non_coding_transcript_exon_variant | 6/8 | ||||
RBMX | NR_028477.2 | n.907A>G | non_coding_transcript_exon_variant | 7/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBMX | ENST00000320676.11 | c.717A>G | p.Arg239Arg | synonymous_variant | 7/9 | 1 | NM_002139.4 | ENSP00000359645.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183449Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67893
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1097910Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363290
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Jul 18, 2020 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at